159 related articles for article (PubMed ID: 10438663)
1. Impaired glutamate clearance as a consequence of energy failure caused by MPP(+) in astrocytic cultures.
Di Monte DA; Tokar I; Langston JW
Toxicol Appl Pharmacol; 1999 Aug; 158(3):296-302. PubMed ID: 10438663
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of the 1-methyl-4-phenyl-2,3-dihydropyridinium and 1-methyl-4-phenylpyridinium species in primary cultures of mouse astrocytes.
Wu EY; Langston JW; Di Monte DA
J Pharmacol Exp Ther; 1992 Jul; 262(1):225-30. PubMed ID: 1625201
[TBL] [Abstract][Full Text] [Related]
3. Toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes.
Di Monte DA; Wu EY; Delanney LE; Irwin I; Langston JW
J Pharmacol Exp Ther; 1992 Apr; 261(1):44-9. PubMed ID: 1560384
[TBL] [Abstract][Full Text] [Related]
4. Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytes.
Di Monte DA; Wu EY; Irwin I; Delanney LE; Langston JW
Glia; 1992; 5(1):48-55. PubMed ID: 1311704
[TBL] [Abstract][Full Text] [Related]
5. Edaravone protects against MPP+ -induced cytotoxicity in rat primary cultured astrocytes via inhibition of mitochondrial apoptotic pathway.
Chen H; Wang S; Ding JH; Hu G
J Neurochem; 2008 Sep; 106(6):2345-52. PubMed ID: 18643790
[TBL] [Abstract][Full Text] [Related]
6. Differences in the disposition and toxicity of 1-methyl-4-phenylpyridinium in cultured rat and mouse astrocytes.
Tsai MJ; Lee EH
Glia; 1994 Dec; 12(4):329-35. PubMed ID: 7890335
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of glutamate uptake in 1-methyl-4-phenylpyridinium-treated astrocytes by trichostatin A.
Wu JY; Niu FN; Huang R; Xu Y
Neuroreport; 2008 Aug; 19(12):1209-12. PubMed ID: 18628666
[TBL] [Abstract][Full Text] [Related]
8. Effects of enhancing mitochondrial oxidative phosphorylation with reducing equivalents and ubiquinone on 1-methyl-4-phenylpyridinium toxicity and complex I-IV damage in neuroblastoma cells.
Mazzio EA; Soliman KF
Biochem Pharmacol; 2004 Mar; 67(6):1167-84. PubMed ID: 15006552
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of glutamate uptake mediates the neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes.
Yao HH; Ding JH; Zhou F; Wang F; Hu LF; Sun T; Hu G
J Neurochem; 2005 Feb; 92(4):948-61. PubMed ID: 15686497
[TBL] [Abstract][Full Text] [Related]
10. Iptakalim ameliorates MPP+-induced astrocyte mitochondrial dysfunction by increasing mitochondrial complex activity besides opening mitoK(ATP) channels.
Zhang S; Ding JH; Zhou F; Wang ZY; Zhou XQ; Hu G
J Neurosci Res; 2009 Apr; 87(5):1230-9. PubMed ID: 19006086
[TBL] [Abstract][Full Text] [Related]
11. MPP(+) causes inhibition of cellular energy supply in cerebellar granule cells.
González-Polo RA; Soler G; Alonso JC; Rodríguez-Martín A; Fuentes JM
Neurotoxicology; 2003 Mar; 24(2):219-25. PubMed ID: 12606294
[TBL] [Abstract][Full Text] [Related]
12. MPP(+)-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport.
Desai VG; Feuers RJ; Hart RW; Ali SF
Brain Res; 1996 Apr; 715(1-2):1-8. PubMed ID: 8739616
[TBL] [Abstract][Full Text] [Related]
13. Uncoupling of ATP-depletion and cell death in human dopaminergic neurons.
Pöltl D; Schildknecht S; Karreman C; Leist M
Neurotoxicology; 2012 Aug; 33(4):769-79. PubMed ID: 22206971
[TBL] [Abstract][Full Text] [Related]
14. Glutamate uptake inhibitor L-trans-pyrrolidine 2,4-dicarboxylate becomes neurotoxic in the presence of subthreshold concentrations of mitochondrial toxin 3-nitropropionate: involvement of mitochondrial reducing activity and ATP production.
García O; Massieu L
J Neurosci Res; 2003 Dec; 74(6):956-66. PubMed ID: 14648602
[TBL] [Abstract][Full Text] [Related]
15. The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.
Lannuzel A; Michel PP; Höglinger GU; Champy P; Jousset A; Medja F; Lombès A; Darios F; Gleye C; Laurens A; Hocquemiller R; Hirsch EC; Ruberg M
Neuroscience; 2003; 121(2):287-96. PubMed ID: 14521988
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades.
Matos M; Augusto E; Oliveira CR; Agostinho P
Neuroscience; 2008 Oct; 156(4):898-910. PubMed ID: 18790019
[TBL] [Abstract][Full Text] [Related]
17. The use of astrocytes in culture as model systems for evaluating neurotoxic-induced-injury.
Aschner M; Kimelberg HK
Neurotoxicology; 1991; 12(3):505-17. PubMed ID: 1684034
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide protects astrocytes against H(2)O(2)-induced neural injury via enhancing glutamate uptake.
Lu M; Hu LF; Hu G; Bian JS
Free Radic Biol Med; 2008 Dec; 45(12):1705-13. PubMed ID: 18848879
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
Hurtado O; Moro MA; Cárdenas A; Sánchez V; Fernández-Tomé P; Leza JC; Lorenzo P; Secades JJ; Lozano R; Dávalos A; Castillo J; Lizasoain I
Neurobiol Dis; 2005 Mar; 18(2):336-45. PubMed ID: 15686962
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes.
Bal-Price A; Moneer Z; Brown GC
Glia; 2002 Dec; 40(3):312-23. PubMed ID: 12420311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
